Certolizumab pegol (Certolizumab) is a recombinant, polyethylene glycosylated, antigen-binding fragment of a humanized monoclonal antibody that selectively targets and neutralizes tumour necrosis factor-alpha (TNF-alpha). Certolizumab pegol can be used for rheumatoid arthritis and Crohn disease research[1][2].
Molecular Weight:
(91 kDa)
Purity:
99.30
CAS Number:
[428863-50-7]
Target:
TNF Receptor
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted